Appointment of Dawn Allen as CFO | 24-Apr-2024 | 07:00 | RNS |
Notice of Annual General Meeting (AGM) | 12-Apr-2024 | 12:00 | RNS |
Director/PDMR Shareholding | 03-Apr-2024 | 11:30 | RNS |
Total Voting Rights and Capital | 02-Apr-2024 | 09:15 | RNS |
Holding(s) in Company | 22-Mar-2024 | 11:30 | RNS |
Haleon | 21-Mar-2024 | 18:00 | RNS |
Total Voting Rights and Capital | 21-Mar-2024 | 16:38 | RNS |
Closing of Secondary Global Offering by Pfizer | 21-Mar-2024 | 16:05 | RNS |
Final prospectus supplement filed with the SEC | 20-Mar-2024 | 08:39 | RNS |
Pricing and upsize of Secondary Global Offering | 19-Mar-2024 | 07:00 | RNS |
Preliminary prospectus supplement filed with SEC | 18-Mar-2024 | 11:00 | RNS |
Proposed Secondary Global Offering by Pfizer Inc. | 18-Mar-2024 | 07:00 | RNS |
Publication of Annual Report and Form 20-F 2023 | 15-Mar-2024 | 15:00 | RNS |
Director/PDMR Shareholding | 14-Mar-2024 | 16:20 | RNS |
Director/PDMR Shareholding | 12-Mar-2024 | 15:30 | RNS |
Currency | UK Pounds |
Share Price | 329.90p |
Change Today | 0.30p |
% Change | 0.09 % |
52 Week High | 353.00 |
52 Week Low | 308.55 |
Volume | 2,123,031 |
Shares Issued | 9,132m |
Market Cap | £30,128m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 14-Mar-24 | 24-Aug-23 |
Paid | 16-May-24 | 05-Oct-23 |
Amount | 4.20p | 1.80p |
Time | Volume / Share Price |
10:15 | 313 @ 329.90p |
10:15 | 244 @ 329.80p |
10:15 | 383 @ 329.80p |
10:15 | 383 @ 329.80p |
10:15 | 336 @ 329.80p |
You are here: research